Company: MIRM
Filing Date: 2025-11-17
Form Type: 8-K
Source: 0001759425-25-000057
Chunk: 1

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-11-17
Form: 8-K
Item: Item 8.01
Chunk 1
---
 Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as “intend,” “may,” “potential,” and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Mirum’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Actual results could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties, which include, without limitation, risks and uncertainties associated with Mirum’s business in general, the impact of geopolitical and macroeconomic events, and the other risks described in Mirum’s Annual Report for the year ended December 31, 2024, filed with the Securities and Exchange Commission on February 26, 2025, and subsequent filings with the Securities and Exchange Commission, which are available at www. sec. gov. All forward-looking statements contained in this report speak only as of the date on which they were made and are based on management’s assumptions and estimates as of such date. Mirum undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                               Mirum Pharmaceuticals, Inc.                               
  Date: November 17, 2025      By:                              /s/ Christopher Peetz    
                                                                Christopher Peetz        
                                                                Chief Executive Officer